OmniStar Financial Group Inc. Boosts Stock Position in The Clorox Company $CLX

OmniStar Financial Group Inc. boosted its position in The Clorox Company (NYSE:CLX) by 16.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,077 shares of the company’s stock after buying an additional 1,440 shares during the period. OmniStar Financial Group Inc.’s holdings in Clorox were worth $1,210,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. American National Bank & Trust increased its position in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares in the last quarter. NewSquare Capital LLC lifted its position in Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after buying an additional 193 shares in the last quarter. Hantz Financial Services Inc. purchased a new stake in Clorox in the 2nd quarter valued at $31,000. Ransom Advisory Ltd acquired a new stake in Clorox during the first quarter worth about $35,000. Finally, GW&K Investment Management LLC raised its position in shares of Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after buying an additional 208 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Barclays decreased their target price on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research note on Tuesday, November 4th. Jefferies Financial Group reissued a “buy” rating and set a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. Rothschild & Co Redburn dropped their price objective on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Bank of America decreased their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Finally, UBS Group set a $119.00 target price on shares of Clorox and gave the company a “neutral” rating in a report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $125.69.

Insider Activity at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $103.52 on Friday. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a 1-year low of $103.43 and a 1-year high of $171.37. The business’s 50-day simple moving average is $117.67 and its 200-day simple moving average is $123.73. The firm has a market capitalization of $12.63 billion, a P/E ratio of 15.88, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the business posted $1.86 EPS. The company’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. The ex-dividend date was Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.8%. Clorox’s dividend payout ratio (DPR) is 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.